Sign in
MYNZ Stock Price, Chart, Stats & News
Mainz Biomed B.V.
Save
14.69M
Market cap
–
Current P/E
–
Forward P/E
MYNZ chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -8.26% |
Operating margin | -2572.89% |
Pretax margin | -2874.69% |
Net margin | -2874.69% |
Effective tax rate | – |
ROA | -193.51% |
ROE | -442.79% |
D/E | 1.23x |
Interest coverage ratio | -13.16x |
MYNZ valuation
P/E | – |
P/S | 4.34x |
P/B | 0.87x |
P/CF | -0.14x |
P/FCF | -0.18x |
P/OCF | -0.14x |
PEG | -0.00x |
EV multiple | -0.09x |
About
Mainz Biomed B. V. is a German company specializing in molecular genetics for the development of cancer diagnostics. The firm engineers both in-vitro diagnostic (IVD) tools and assays designed exclusively for research, primarily catering to clinical applications within human genetics.
Similar securities
Based on sector and market capitalization
Report issue